Alcohol Screening in an Ethnically Diverse Sample of Adolescents in Primary Care
|ClinicalTrials.gov Identifier: NCT01797835|
Recruitment Status : Active, not recruiting
First Posted : February 25, 2013
Last Update Posted : September 27, 2017
|Condition or disease||Intervention/treatment||Phase|
|Alcohol Use Drug Use||Behavioral: CHAT brief MI intervention Behavioral: usual care||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1573 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Alcohol Screening in an Ethnically Diverse Sample of Adolescents in Primary Care|
|Study Start Date :||March 2013|
|Actual Primary Completion Date :||November 2015|
|Estimated Study Completion Date :||August 2018|
Placebo Comparator: Usual Care
Youth in usual care will receive screening for alcohol and drug use. Those youth who are at risk will have a chance to talk to their provider about their use. They will also receive an informational brochure.
Behavioral: usual care
Youth receive a brochure with information on AOD use.
Experimental: CHAT brief MI intervention
Youth in CHAT will receive screening for alcohol and drug use. Those youth who are at risk will have a chance to talk to their provider about their use. In addition, these youth will CHAT. CHAT is a brief motivational intervention that takes places in the primary care setting. It is a 15-20 minute intervention for adolescents age 12-18 focused on discussing alcohol and drug use. They will also receive a booster call one month later to check in on how they are doing.
Behavioral: CHAT brief MI intervention
CHAT is one 15-20 minute session delivered in a single PC visit and utilizes motivational interviewing with youth to target alcohol and drug use in primary care.
- Alcohol use [ Time Frame: Past 30 days ]in the past 30 days: Number of times used alcohol, number of drinks, number of heavy drinking days
- marijuana use [ Time Frame: past 30 days ]number of times used marijuana in the past 30 days
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01797835
|United States, California|
|Valley Community Clinic|
|North Hollywood, California, United States, 91605|
|United States, Pennsylvania|
|UPMC St. Margaret|
|Pittsburgh, Pennsylvania, United States, 15215|
|Principal Investigator:||Elizabeth J D'Amico, PhD||RAND|